Trials / Completed
CompletedNCT02840708
SK-1401 (rhGM-CSF Agent for Inhalation) GM-CSF Inhalation Pharmacokinetic Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Niigata University Medical & Dental Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Objective: Evaluate Pharmacokinetics and determine the safety of GM-CSF single dose inhalation. Study Design: Pharmacokinetic open study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sargramostim |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-12-01
- Completion
- 2017-09-01
- First posted
- 2016-07-21
- Last updated
- 2017-12-18
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02840708. Inclusion in this directory is not an endorsement.